Human Pheromone Sciences (EROX) Stock Price, News & Analysis

Company Overview

Human Pheromone Sciences, Inc. (OTCMKTS: EROX) is a biotechnology company dedicated to the research and development of human pheromone-based products. The company investigates the role of pheromones in human behavior, with a focus on formulations that may influence interpersonal communication, mood regulation and wellness. Its scientific team conducts preclinical studies to identify and isolate pheromone compounds that can be incorporated into personal care and consumer health applications.

Building on its research platform, Human Pheromone Sciences aims to develop proprietary delivery systems for pheromone-enhanced products, such as topical applications, fragrances and other personal care items. The company’s product pipeline remains at a pre-commercial stage, and it is working toward the validation of safety and efficacy through internal testing and potential external collaborations. Its R&D efforts emphasize non-invasive approaches and compliance with relevant regulatory guidelines.

Headquartered in the United States, Human Pheromone Sciences serves a domestic market and is positioning itself for broader commercialization once its lead candidates complete required evaluations. The company’s management team comprises professionals with backgrounds in biochemistry, dermatology and consumer product development, although specific leadership details are not publicly disclosed. As a small‐cap issuer on the OTC Markets, Human Pheromone Sciences continues to advance its scientific programs while seeking potential strategic partnerships to support future product launches.

Key Stats

• Today's Range: $0.0004 to $0.0004
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.13
• Volume: N/A
• Average Volume: 13,574 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EROX Stock Analysis - Frequently Asked Questions

How have EROX shares performed this year?

Human Pheromone Sciences' stock was trading at $0.0004 on January 1st, 2025. Since then, EROX stock has increased by 0.0% and is now trading at $0.0004.

How do I buy shares of Human Pheromone Sciences?

Shares of EROX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Toilet Preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EROX
• CIK: N/A
• Web: www.naturalattraction.com
• Phone: (408) 938-3030
• Fax: 408-938-3025
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 3.30